Citrobacter Koserii as a Cause of Urinary Tract Infection: A Case Report

Camargo Camargo Edgar David^1, , Obeid Angulo Emil José², Olmos Tovio Leisy Sandrid², Robles Bolivar Carlos Steven², Monroy López Lina María³, Ladino Gil Karla Juliana⁴ and Córdoba Imbachi Alejandro⁵

¹Medical Intern of Libre Univsersity, Barranquilla, Atlántico, Colombia

²Medical General of Rafael Núñez University Corporation , Cartagena, Bolívar, Colombia

³First Year Resident in Internal Medicine of Metropolitan University, Barranquilla, Atlántico, Colombia

⁴Medical Intern of South Colombian University, Neiva, Huila, Colombia

⁵Fourth Year Medical Student, Medical Intern of South Colombian University, Neiva, Huila, Colombia

Cite this paper

Camargo Camargo Edgar David, Obeid Angulo Emil José, Olmos Tovio Leisy Sandrid, Robles Bolivar Carlos Steven, Monroy López Lina María, Ladino Gil Karla Juliana and Córdoba Imbachi Alejandro. Citrobacter Koserii as a Cause of Urinary Tract Infection: A Case Report. American Journal of Medical Case Reports. 2022; 10(12):319-322. doi: 10.12691/AJMCR-10-12-6

Abstract

Urinary tract infection (UTI) is one of the most common bacterial infections, affecting up to 150 million people worldwide, and certain host conditions predispose urinary tract infection to be considered complicated and therefore warrant broad-spectrum empirical treatment, in the elderly, complicated urinary tract infection should always be considered within the range of diagnoses, as the symptoms and signs for which they consult the emergency department are often very nonspecific, although this leads to overdiagnosis and overtreatment of this condition. Should not be limited to suspicion, especially if the patient has clinical conditions that assert the risk of a complicated UTI, as happened in the case of our index patient: An 83 year old adult with a history of Alzheimer's disease and urinary incontinence, admitted because he showed fever of 2 days of evolution and foul-smelling urine. A urine sample was taken for urinalysis which was suggestive of urinary tract infection and a urine culture showed infection by Citrobacter koserii. Knowing the susceptibility profile, it was decided to rotate to ciprofloxacin and continued new antibiotic treatment until completing 10 days counting as effective the days in which he received Piperacillin/tazobactam, presenting good evolution until medical discharge.

Keywords

urinary tract infection, elderly patients, antibiotic therapy

Copyright

This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References

[1]	Flores-Mireles AL, Walker JN, Caparon M, Hultgren SJ. Urinary tract infections: epidemiology, mechanisms of infection and treatment options. Nat Rev Microbiol. mayo de 2015; 13(5): 269-84.
[2]	Dubbs SB, Sommerkamp SK. Evaluation and Management of Urinary Tract Infection in the Emergency Department. Emergency Medicine Clinics of North America. noviembre de 2019; 37(4): 707-23.
[3]	Long B, Koyfman A. The Emergency Department Diagnosis and Management of Urinary Tract Infection. Emergency Medicine Clinics of North America. 1 de noviembre de 2018; 36(4): 685-710.
[4]	Takhar SS, Moran GJ. Diagnosis and Management of Urinary Tract Infection in the Emergency Department and Outpatient Settings. Infectious Disease Clinics of North America. marzo de 2014; 28(1): 33-48.
[5]	Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. The American Journal of Medicine. 8 de julio de 2002; 113 (1, Supplement 1): 14-9.
[6]	Hernández ALD, Escalante SA, Escobar GAB. Identificación de Citrobacter koseri como nuevo patógeno en pacientes con rinitis crónica. Otorrinolaringología. 2014; 59(1): 1-10.
[7]	Samonis G, Karageorgopoulos DE, Kofteridis DP, Matthaiou DK, Sidiropoulou V, Maraki S, et al. Citrobacter infections in a general hospital: characteristics and outcomes. Eur J Clin Microbiol Infect Dis. 6 de agosto de 2008; 28(1): 61.
[8]	Doran TI. The Role of Citrobacter in Clinical Disease of Children: Review. 11.
[9]	Zeng G, Zhu W, Lam W, Bayramgil A. Treatment of urinary tract infections in the old and fragile. World J Urol. noviembre de 2020; 38(11): 2709-20.
[10]	Curns AT, Holman RC, Sejvar JJ, Owings MF, Schonberger LB. Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med. 28 de noviembre de 2005; 165(21): 2514-20.
[11]	Griebling TL. Urologic diseases in america project: trends in resource use for urinary tract infections in men. J Urol. abril de 2005; 173(4): 1288-94.
[12]	EAU-Guidelines-on-Urological-Infections-2022.pdf [Internet]. [citado 16 de julio de 2022]. Disponible en: https://d56bochluxqnz.cloudfront.net/documents/full-guideline/EAU-Guidelines-on-Urological-Infections-2022.pdf
[13]	Caljouw MAA, den Elzen WPJ, Cools HJM, Gussekloo J. Predictive factors of urinary tract infections among the oldest old in the general population. A population-based prospective follow-up study. BMC Med. 16 de mayo de 2011; 9: 57.
[14]	High KP, Bradley S, Loeb M, Palmer R, Quagliarello V, Yoshikawa T. A new paradigm for clinical investigation of infectious syndromes in older adults: assessment of functional status as a risk factor and outcome measure. Clin Infect Dis. 1 de enero de 2005; 40(1): 114-22.
[15]	Richards CL. Urinary tract infections in the frail elderly: Issues for diagnosis, treatment and prevention. Int Urol Nephrol. 1 de septiembre de 2004; 36(3): 457-63.
[16]	GPC-infeccion-de-vias-urinarias.pdf [Internet]. [citado 26 de septiembre de 2022]. Disponible en: https://www.revistamedicaclcountry.com/app/default/files-module/local/documents/GPC-infeccion-de-vias-urinarias.pdf.
[17]	Guzmán N, García-Perdomo HA. Novedades en el diagnóstico y tratamiento de la infección de tracto urinario en adultos. 79: 14.
[18]	Deveci A, Coban AY. Optimum management of Citrobacter koseri infection. Expert Review of Anti-infective Therapy. 1 de septiembre de 2014; 12(9): 1137-42.
[19]	Clinical and molecular epidemiology of multidrug-resistant Citrobacter spp. infections in a French university hospital | SpringerLink [Internet]. [citado 26 de septiembre de 2022]. Disponible en: https://link.springer.com/article/10.1007/s10096-007-0315-3.
[20]	Fàbrega A, Madurga S, Giralt E, Vila J. Mechanism of action of and resistance to quinolones. Microb Biotechnol. enero de 2009; 2(1): 40-61.